NDC 50419-250 – Adempas

Riociguat .5 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC50419-250

Product details

Brand name
Adempas
Generic name
riociguat
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA204819
Marketed since
October 8, 2013
Listing expires
December 31, 2027
Pharmacologic class
Soluble Guanylate Cyclase Stimulator

Active ingredients

Uses, dosage, side effects and warnings for Adempas →

Package NDC codes (4)

Package NDCDescriptionSince
50419-250-0190 TABLET, FILM COATED in 1 BOTTLE (50419-250-01)Oct 8, 2013
50419-250-032 BLISTER PACK in 1 PACKAGE (50419-250-03) / 21 TABLET, FILM COATED in 1 BLISTER PACKOct 8, 2013
50419-250-7190 TABLET, FILM COATED in 1 BOTTLE (50419-250-71)Oct 8, 2013
50419-250-919 TABLET, FILM COATED in 1 BOTTLE (50419-250-91)Sep 18, 2014

Other Adempas products